Therapeutic human anti-IL1-R1 monoclonal antibody
US7438910B2 · kind B2 · utility
25Cited by
14References
34Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 5, 2003 |
| Grant date | Oct 21, 2008 |
| Priority date | — |
| Expiry date | Sep 5, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies that interact with interleukin-1 receptor type 1 (IL-1R1) are described. Methods of treating IL-1 mediated diseases by administering a pharmaceutically effective amount of antibodies to IL-1R1 are described. Methods of detecting the amount of IL-1R1 in a sample using antibodies to IL-1R1 are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.